To evaluate the targeting efficiency, pattern, and reflect the target distribution.
Creative Biolabs delivers a complete, high-fidelity solution for ADC analytical characterization and validation, bridging the gap between molecular complexity and project success. By integrating real-time DAR monitoring, ultra-sensitive free-payload impurity detection, and predictive 3D functional assays, we provide the technical depth necessary to advance your ADC research with total confidence. Our customized protocols ensure that every aspect of your bioconjugate's structural and functional profile is meticulously validated to meet the highest scientific research standards.
The assembling of an antibody-drug conjugate (ADC) is the covalent coupling of a critical monoclonal antibody and a druggable payload through a specific linker molecule. The final goal of ADC discovery and development is to deploy the ADC candidate into animal models and eventually patients, to treat cancer utilizing the payload efficacy of the ADC. Before deploying the ADC candidate into in vivo systems, in vitro analytical characterization and validation are necessary to capture the basic biochemical characteristics and in vitro efficacy data to evaluate the ADC project. Creative Biolabs provides a series of ADC in vitro analytical characterization and validation services to determine the biochemistry and efficacy of the ADC candidate, which can provide directions and guidelines for project progression.
Fig.1 LB-LC-MS/MS methods for ADC bioanalysis and validation. 1
Creative Biolabs offers a comprehensive set of in vitro analytical characterization and validation services, including: (but not limited to)
Biochemical Analysis
We offer biochemical analysis to determine the structure, stability, and drug conjugation pattern of the assembled ADC.
To evaluate the structure of the antibody or antibody fragment to ensure correct folding after payload chemistry conjugation.
To determine the payload drug to antibody molar ratio, as well as the distribution pattern of various DAR species via chromatography and mass spectroscopy analysis.
To evaluate the physical stability (auto-fragmentation, aggregation, thermal stability, solubility), chemical stability (in vitro minimum payload release at non-desired buffer, antibody reactivity during and after chemistry conjugation), and serum stability, etc.
To offer the analytical results of conjugated payload-linker location sites through mass spectroscopy, as well as the conjugation information about the unreacted payload-linker on the target antibody.
In Vitro Efficacy Studies
We offer in vitro efficacy studies to evaluate the cytotoxicity of the constructed ADC utilizing various assays.
To measure the cell viability in a dosage-dependent manner, utilizing antigen-expressing cell lines.
To determine the antigen and Fc receptor binding affinity via different approaches, including ELISA, flow cytometry, and surface plasmon resonance (SPR).
To perform antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) assays to provide more details about the pharmacological effects of the ADC.
3D In Vitro Platform
To mimic the tumor treatment, we offer a 3D in vitro platform to evaluate the behavior and cytotoxicity of an ADC using innovative antigen-expressing 3D cultured cells.
To evaluate the targeting efficiency, pattern, and reflect the target distribution.
To provide a 3D distribution profile of the ADC in tumors.
To measure the efficacy of an ADC in a whole regime that can accurately mimic the scenarios of tumors.
We utilize high-resolution analytical instrumentation to ensure molecular clarity and exceptional data precision throughout every stage of development.
Our highly experienced technical team provides deep scientific insights to help researchers navigate complex biochemical and structural challenges.
We offer in vitro characterization services covering everything from initial screening to complete functional and structural validation.
Every project receives tailored analytical strategies designed to address specific research goals and unique molecular requirements effectively.
Discover how we can help - Get a quote today.
We utilize specialized analytical methods and optimized mobile phases to ensure hydrophobic species are accurately characterized without artificial aggregation or loss.
Yes, our advanced platforms independently quantify active conjugates versus total antibody forms, providing a precise understanding of potential research efficacy and potency.
High-throughput identification of antibody candidates based on target binding affinity and efficient cellular internalization rates.
Learn More →Specialized aseptic processing and formulation development for high-potency bioconjugates to ensure product integrity and long-term stability.
Learn More →ADC has emerged as a promising immunotherapy with high potential in the treatment of cancer. Creative Biolabs offers a series of in vitro assays to provide accurate guidelines for ADC optimization and in vivo testing in the next stage. We are dedicated to providing customized solutions to tailor a specific service package. Any questions, please feel free to contact us for more information and a detailed quote.
Reference